Skip to main content

Govt building

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure access Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Efficacy of Nadolol Alone and Combined with Bendroflumethiazide and Hydralazine for Systemic Hypertension

 Digital Record
Identifier: 101584929X79
Digital Object (text)

Go to file

Dates

  • Publication: 1 December 1983

Extent

8 pages

Description

In this article, the Veterans Administration Cooperative Study Group reported that nadolol, a beta-blocker, and bendroflumethiazide, a diuretic, appeared to be safe and effective antihypertensive agents with minimal side effects. They noted that nadolol was more effective in white patients, while bendroflumethiazide worked better in black patients.

Language of Materials

English

Additional Description

Original Profiles System Identifier

XFBBFV

Source Category

Periodical

Veterans Administration Cooperative Study Group on Antihypertensive Agents. "Efficacy of Nadolol Alone and Combined with Bendroflumethiazide and Hydralazine for Systemic Hypertension." The American Journal of Cardiology 52, (1 December 1983): 1230-1237. Article. 8 Images.

The American Journal of Cardiology

Physical Description

Physical Condition - Good

Subjects

Linked Records

Collecting Area Details

Collecting Area Details

Part of the Archives and Modern Manuscripts Collections Collecting Area

Contact:
8600 Rockville Pike
Bldg 38/1E-21, MSC 3819
Bethesda MD 20894 US
1-888-FINDNLM (1-888-346-3656)